HomeBUSINESS
BUSINESS

Fujifilm Kicks Off PI Study on FLT3 Inhibitor in US
(Aug.9.2017)

Fujifilm said on August 8 that it has launched a PI clinical trial for its FLT3 inhibitor FF-10101 in the US for the treatment of released/refractory acute myeloid leukemia (AML). The company is eyeing the drug’s launch for this indication in 2022 ...
(LOG IN FOR FULL STORY)

Notice

 The next ebook update will be provided on August 28.

News Calendar